<DOC>
	<DOCNO>NCT02754570</DOCNO>
	<brief_summary>The aim study determine effect pilocarpine adjunct medication latanoprost monotherapy multiple interval throughout 24-hour period compare effect latanoprost alone .</brief_summary>
	<brief_title>The Diurnal Nocturnal Effect Pilocarpine Intraocular Pressure Ocular Perfusion Pressure</brief_title>
	<detailed_description>This study plan learn effect pilocarpine intraocular pressure ocular perfusion pressure full twenty-four hour period . In study , investigator seek good characterize knowledge base intraocular pressure ( IOP ) lower effect pilocarpine patient open angle glaucoma ocular hypertension currently take latanoprost . The goal define potential additive effect pilocarpine throughout 24-hour period , IOP , ocular perfusion pressure ( defined 2/3 [ diastolicBP + 1/3 ( systolicBP - diastolicBP ) ] - IOP ) . These data allow expand current knowledge effect pilocarpine help determine medication useful role adjunctive treatment glaucoma .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Pilocarpine</mesh_term>
	<criteria>Current confirm diagnosis : open angle glaucoma , ocular hypertension include pigment dispersion glaucoma , pseudoexfoliation glaucoma . Current use topical latanoprost day eye least 6 week race/ethnicity Females currently pregnant plan become pregnant study period Diagnosis form glaucoma openangle Intraocular pressure reading &lt; 14mmHg either eye measure routine office visit past 12 month . Schaffer angle grade &lt; 2 either eye gonioscopy Intraocular surgery within 6 month laser within 3 month History retinal tear detachment either eye Active iritis either eye determine recent eye examination Patients smoke irregular daily sleep pattern Patients start changed glucocorticoid therapy last 3 month Patients currently use medical recreational marijuana Any use nonFDA approve medication glaucoma last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>Latanoprost</keyword>
	<keyword>Pilocarpine</keyword>
</DOC>